Anti-CD20 monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus.
Borradori
L
L
Department of Dermatology, University Hospital, Rue Micheli du Crest 24, CH-1211 Genève 14, Switzerland. Luca.Borradori@hcuge.ch
Lombardi
T
T
Samson
J
J
Girardet
C
C
Saurat
J H
JH
Hügli
A
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000032:analysis / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000150:complications / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D009061:Mouth Mucosa / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D010392:Pemphigus / Q000150:complications* / Q000276:immunology / Q000473:pathology; D000069283:Rituximab; D013280:Stomatitis / Q000150:complications / Q000276:immunology / Q000473:pathology* / Q000628:therapy*
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab